Abitare In SpA
MIL:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abitare In SpA
MIL:ABT
|
IT |
|
B
|
BHP Group Ltd
XMUN:BHP
|
AU |
|
Immix Biopharma Inc
NASDAQ:IMMX
|
US |
|
Theravance Biopharma Inc
NASDAQ:TBPH
|
KY |
|
H
|
Hankuk Steel Wire Co Ltd
KOSDAQ:025550
|
KR |
|
Aerometrex Ltd
ASX:AMX
|
AU |
|
W
|
Wanted Lab Inc
KOSDAQ:376980
|
KR |
|
Colgate-Palmolive Co
NYSE:CL
|
US |
|
Astrotech Corp
F:SP5
|
US |
|
Yunfeng Financial Group Ltd
F:MNA1
|
HK |
|
E
|
Entravision Communications Corp
F:EV9
|
US |
Intrinsic Value
Is ABT undervalued or overvalued?
See the intrinsic value estimate for Abitare In SpA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ABT looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ABT’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Abitare In SpA Does
Abitare In SpA is an Italian residential real estate developer. It buys land or redevelopment sites, plans apartment projects, and sells the finished homes, mainly in and around Milan. Its business is centered on creating new housing rather than holding buildings for rent or running a broad property portfolio.
- Headquarters
- Italy IT
- Employees
- 47
- IPO date
- Apr 8, 2016
Revenue & Expenses Breakdown
Abitare In SpA
Earnings Waterfall
Abitare In SpA
The intrinsic value for Abitare In SpA (ABT) under the Base Case is hidden EUR.
Compared with the current market price of 2.72 EUR, the stock appears hidden.